Hi-Risk/Recurrent/Advanced PCa Video Chat, Feb 25, 2025

by | Feb 26, 2025 | Cancer Resources, High Risk/Recurrent/Advanced, High Risk/Recurrent/Advanced Prostate Cancer, nmCRPC, Prostate Cancer, Recorded Groups

Intermediate Risk Prostate Cancer Graphic

Hi-Risk/Recurrent/Advanced PCa Video Chat, Feb 25, 2025

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostic.
If you missed any recent recordings, you’ll find a full list either on our YouTube Playlist or visit our Blog Post https://ancan.org/our-recent-blog-posts-in-case-you-missed-them/   Sign up for our Blog by checking the New Blog box at https://ancan.org/contact-us/
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
All AnCan’s groups are free and drop-in … join us in person sometime!
Join our other free and drop in groups:

Editor’s Pick: Will estradiol replace the hated ADT?

Topics Discussed

After a few rounds of, “Hmm, this is worse than we expected,” he aims to get ahead of the curve; off ADT, and waiting apprehensively for his bloodwork; exciting news from Dr. Wassersug about estradiol — no hot flashes, preserves bone density, the patches are cheap, and they’re already available (but for women); surgery or cortisone for his trigger-finger syndrome — and is it ADT-related?; was PSA spike due to a faded 6-month Eligard shot?; doc sees results and says, “Let’s start the drug holiday now!”; what’s a crosslink collagen test?; Pluvicto trial’s four-month survival gain feels troublingly small; doc wanted to keep chemo in a back pocket — is it time?; “what’s impacting my life most now is a shortness of breath” — a cardio-oncologist might help;  after a week of Orgovyx he feels no change…but ADT’s side effects develop over time.

Chat Log

Steve Roux, North Michigan · 6:49 PM
Matthew – sign up for the reminder emails for meeting reminders and a lot of other good stuff.

Jim Marshall, Alexandria, VA · 6:49 PM
1st & 3rd Mondays at 08:00pmET and 2nd  & 4th Tuesdays at 06:00pmET    High Risk Group

Jerry Grimes, Brighton, MI · 6:56 PM
I am on estradiol, through informed consent.  I feel great.  Can confirm Dr. Wassersug’s comments about symptom relief.

Jerry Grimes, Brighton, MI · 7:00 PM
I was paying approx $140 per 3 months for two 0.1mg/day patches, changed twice weekly.

Jerry Grimes, Brighton, MI · 7:01 PM
My insurance did not cover this.

John  M · 7:05 PM
Robert: Which ADT drug were you on?

Matthew L · 7:09 PM
the names are gone. at each person on the main screen how what happen

AnCan  – rick · 7:10 PM
Make the window larger

Steve Roux, North Michigan · 7:10 PM
👍

Steve  L · 7:11 PM
names gone if one person has enlarged image but names present if all small images.

 

AnCan  – rick · 7:42 PM
David Smith, GU MO at Uof M (Go Blue)!! https://www.rogelcancercenter.org/physicians/david-c-smith-md

AnCan  – rick · 7:47 PM
👍

Jim Marshall, Alexandria, VA · 7:49 PM
Pluvicto and ATM mutation says it works very well.    jim marshall

AnCan  – rick · 8:14 PM
Effie Andrikopoulou, MD

AnCan  – rick · 8:14 PM
https://www.uwmedicine.org/bios/effie-andrikopoulou